OrthoLogic changes indication for spinal fusion product
This article was originally published in Clinica
Executive Summary
OrthoLogic has submitted an amended premarket approval supplement for its SpinaLogic-1000 spinal fusion devices to the US FDA. The changes were made in response to questions put forward by the FDA at a meeting in mid December last year.